N-(IMIDAZO[l,2-B]PYRIDAZIN-3-YL)-l-CYCLOHEXYL-2H-INDAZOLE-5CARBOXAMIDE AND N-(PYRAZOLO[l,5-A]PYRIMIDIN-3-YL)-l-CYCLOHEXYL-2HINDAZOLE-5-CARBOXAMIDE DERIVATIVES AS IRAK4 INHIBITORS FOR THE TREATMENT OF ASTHMA
AP8312AActive Publication Date: 2026-07-20ASTRAZENECA AB
0 Cites 0 Cited by
Patent Information
- Application Number
- AP2023014909
- Authority / Receiving Office
- AP · AP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-12-09
- Publication Date
- 2026-07-20
- Estimated Expiration
- 2041-12-09
Abstract
The present application relates to chemical compounds of Formula (I), and pharmaceutically acceptable salts thereof, that inhibit IRAK4 and consequently have potential utility in medicine.
Need to check novelty before this filing date? Find Prior Art